Lawyers involved in a class-action lawsuit over the drug Rexulti say a $4.75 million settlement has been reached on behalf of patients and the estates and families of those who were prescribed the drug.
The class action involved anyone in Canada who was prescribed the drug between Feb. 16, 2017 and today and experienced compulsive behaviours or impulse-control disorders such as compulsive gambling, hypersexuality, compulsive spending and shopping or binge-eating.
